Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,224,395
-
Number of holders
-
223
-
Total 13F shares, excl. options
-
45,484,033
-
Shares change
-
+2,422,238
-
Total reported value, excl. options
-
$5,854,372,685
-
Value change
-
+$342,578,385
-
Put/Call ratio
-
70%
-
Number of buys
-
138
-
Number of sells
-
76
-
Price
-
$128.71
Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q2 2021
As of 30 Jun 2021 Beam Therapeutics Inc. - COMMON STOCK (BEAM) had 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 45,484,033 shares of stock of the company.
Largest 10 holders included FMR LLC, ARK Investment Management LLC, Temasek Holdings (Private) Ltd, VANGUARD GROUP INC, BlackRock Inc., MWG Management Ltd., Redmile Group, LLC, HHLR ADVISORS, LTD., Farallon Capital Management LLC, and STATE STREET CORP.
This table shows 223 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.